Subject Index
Coagulation Factors and Inhibitors
Fibrinolysis, fibrinogen, fibrin
Haemorrhagic Disorders
Invited
Other
Platelets
Thrombotic Disorders and antithrombotic therapy
Vascular Biology
Thrombotic Disorders and antithrombotic therapy
Animal and experimental models
Antiphospholipid antibodies
Cancer and thrombosis
Cerebrovascular disease
Clinical trials: antiplatelet agents
Clinical trials: direct antithrombin agents
Clinical trials: fibrinolytic therapy
Clinical trials: heparins/LMWH
Clinical trials: oral anticoagulants
Diabetes and metabolic disorders
DVT and pulmonary embolism
Familial thrombosis
Gene therapy
Genetic determinants and epidemiology
Homocysteine
Hormone, pregnancy
Hypercoagulability
Inflammation, infection and immunity
Ischaemic heart disease
New antithrombotic agents and approaches
New intravascular devices
Other thrombotic disorders and antithrombotic therapy
Polymorphism and arterial disease
TTP and HUS
Acquired prothrombotic-associated factors in cerebral venous thrombosis (CVT)
D'Amico E., Camargo E. C. S., Villaça P. R., Massaro A. R., Bassitt R. P., Bacheschi L. A., Scaff M., Chamone D. A. F.
Acute ischemic strokes: LMWHs or aspirin administration and laboratory follow-up
Makris P., Baltatzi M., Iliadis F., Savopoulos C., Girtovitis F., Anestakis D., Hatzitolios A.
Acute ischemic strokes: LMWHs or aspirin administration and laboratory monitoring
Makris P., Baltatzi M., Iliadis F., Savopoulos CH., Girtovitis F., Anestakis D., Hatzitolios A. I.
Arterial ischemic stroke (AIS) in children: a prospective 10-year registry in Argentina
Bonduel M., Sciuccati G., Hepner M., Pieroni G., Feliu Torres A., Frontroth J., Serviddio M. R.
Association between factor XIII Val34Leu polymorphism and risk of ischemic stroke in young patients
Krause M., Zwinge B., Scharrer TH., Vigh I.
Cerebral sinovenous thrombosis (SVT) in children: a prospective 10-year registry in Argentina
Bonduel M., Sciuccati G., Hepner M., Pieroni G., Feliu Torres A., Frontroth J., Serviddio M. R.
Correlation between anti-coagulant therapeutic range and Prothrombin Fragment 1 + 2 in Japanese patients with Cardioembolic Stroke
Nagao T., Katayama Y., Yokochi M.
Correlation between internal carotid artery stenosis and hematological risk factors for thrombosis (CAST study): final results
Camporese G., Tormene D., Verlato F., Zerbinati P., Salmistraro G., Luni S., Simioni P., Girolami A., Andreozzi G. M.
Factor V Leiden, prothrombin G20210A, and MTHFR C677T gene mutations in patients with primary anti-phospholipid syndrome and cerebrovascular disorder
Kalashnikova L., Patrusheva N., Patrushev L., Kovalenko T., Dobrynina L., Alexandrova E., Nassonov E.
Frequency and predictors of vaso-occlusive strokes associated with cardiac surgery in infants and children with congenital heart disease
Domi T., Deveber G., Edgell D., Mccrindle B., Williams W., Macgregor D.
Genetic polymorphisms and the risk of development of ischemic stroke. Result of a case control study
Toulon P., Zuber M., Mas J. L.
Genetic risk factors in patients with myocardial infarction and correlation with echocardiographic study
Paraskevopouloy P., Likousi S., Sotirelos K., Antonatos D., Tsigkas D., Katelani M.
Heparin derived oligosaccharides are capable of passing through the blood brain barrier: experimental evidence in a rat model
Ma Q., Dudas B., Florain-Kujawski M., Cornelli U., Hanin I., Fareed J.
High frequency of combined genetic prothrombotic defects in young patients with ischemic stroke
Pratnicka M., Lewandowski L., Lukasik M., Kolacz E., Czyz A., Kozubski W., Zawilska K., Czyz A.
Hypercoagulability in cerebrovascular disease (CD): factor V Leiden, prothrombin G20210A and MTHFR C677T mutations and polymorphism in the annexin V kozac sequence
De Oña R., Llamas P., Meseguer E., Fernandez De Velasco J., Esheverria A., Rábano J., Vizcarra E., Román A., García De Yébenes J., Tomás J. F.
Increased expression of endogenous tissue-type plasminogen activator and matrix metalloproteinase 9 contribute to heparin-produced cerebral hemorrhage after focal cerebral ischemia in mice
Ikeda Y., Zhao B.-Q., Umemura K., Ihara H., Suzuki Y., Kondo K., Nagai N., Sato K., Urano T.
Increased thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae
Gerlach R., Yahya H., Rohde S., Böhm M., Berkefeld J., Scharrer I., Seifert V., Raabe A.
Interaction between prothrombotic polymorphisms and lupus anticoagulant in chronic cerebrovascular disease
Kapustin S. I., Elchaninov A. P.
Markers of hemostatic activation and protein Z in acute stroke and myocardial infarction: a community based pilot study
Segal H. C., Harrison P., Keeling D., Silver L., Coull A., Rothwell P.
Mild ADAMTS-13 deficiency in patients with ischemic stroke
Böhm M., Peyvandi F., Krause M., Miesbach W., Von Auer C., Scharrer I.
Nitric oxide, cytokine and hemostasis in stroke
Vitkovsky Y., Klimenko O.
Platelet function under aspirin, clopidogrel and both after ischemic stroke. A case-crossover study
Ruf A., Reiners S., Buggle CH., Lichy F., Becher H., Grau A. J.
Population prevalence of atrial fibrillation and factors associated with use of warfarin
Tait R. C., O'Neill K. F., Murdoch D. L., Wallace I. W., Mcmahon A. D., Rumley A., Jackson J., Lowe G. D. O.
Post-treatment of rats with simvastatin affords brain protection after focal ischemia as assessed by magnetic resonance imaging
Sironi L., Cimino M., Guerrini U., Lodetti B., Gelosa P., Paoletti R., Tremoli E.
Serial changes in hemostasis following subarachnoid hemorrhage
Albon H. K., Mcevoy A. W., Mackie I., Kitchen N. D.
Sinus venous thrombosis in children – a multifactorial etiology
Nowak-Goettl U., Heller C. H., Junker R., Knoefler R., Kosch A., Kurnik K., Schobess R., Von Eckardstein A., Zieger B., Straeter R.
The effects of three anti-platelet drugs (aspirin, clopidogrel, dipyridamole) given singly or together on platelet and leukocyte function in healthy subjects and patients with previous ischemic stroke
Zhao L., Fletcher S., Weaver C., Leonardi-Bee J., May J., Fox S., Heptinstall S., Bath P.
The relationship between acute ischemic stroke (AIS) per se and plasma D-D (D-D) levels
Kelly J. A., Lewis R. R., Rudd A., Parmar K., Moody A., Hunt B. J.
The risk of heparin-induced thrombocytopenia and the frequency of heparin-dependent antibodies in neurologic patients treated with unfractionated heparin
Harbrecht U., Bastians B., Kredteck A., Hanfland P., Klockgether T., Pohl C.
The role of thrombophilias in the origin of cerebrovascular accidents at the patients with Atrial Fibrillation
Bokarev I. N., Kozlova T. V., Patrushev L. I., Efimov V. S.
Thrombin generation after ischemic stroke: the hemostatic system activation study (HAS)
Furie K., Thompson J. L. P., Bauer K. A., Rosenberg R., Mohr J. P., Rosner B., Sciacca R., Thornell B. J., Kelly P. J., Barzegar S., Lu Y., Kistler J. P.
Thrombin-activatable fibrinolysis inhibitor is not associated with the occurrence of ischemic stroke
Lee Y. K., Kang H. J., Cho H. C., Lee B., Yu K.
Thrombolytic therapy in acute ischemic stroke: same method, same team, different drug
Szegedi N., May Z., Ovary C., Skopal J., Harsanyi A., Nagy Z.
Thrombophilic risk factors of ischemic stroke in children
Raszeja-Specht A., Pilarska E., Bakowska A., Wróblewska M., Szutowicz A.
Thrombotic risk factors in stroke patients
Ataç B., Özbek N., Can U., Verdi H., Benli S., Kýlýnç M., Çeliker G.
TNF-alpha promoter polymorphisms (-238 and -308) in patients with cerebrovascular disease
De Oña R., Llamas P., Fernandez De Velasco J., Meseguer E., Escheverria A., Rábano J., Santos A., Soto C., Subirá D., Tomás J. F.